A detailed history of Tekla Capital Management LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 66,211 shares of ALXO stock, worth $121,166. This represents 0.02% of its overall portfolio holdings.

Number of Shares
66,211
Previous 66,211 -0.0%
Holding current value
$121,166
Previous $299,000 66.22%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$21.49 - $74.4 $1.27 Million - $4.4 Million
59,112 Added 832.68%
66,211 $1.42 Million
Q3 2021

Nov 12, 2021

BUY
$52.51 - $80.91 $372,768 - $574,380
7,099 New
7,099 $524,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $74.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.